Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review-Reference-Cited by-同舟云学术

Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review

Published:2018-06-22 Issue:10 Volume:14 Page:1344-1376
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Ruthirakuhan Myuri¹²,Lanctôt Krista L.¹²³⁴,Di Scipio Matteo¹,Ahmed Mehnaz¹²,Herrmann Nathan¹³⁴

Affiliation:

1. Hurvitz Brain Sciences ProgramSunnybrook Research InstituteTorontoONCanada

2. Department of Pharmacology and ToxicologyUniversity of TorontoTorontoONCanada

3. Geriatric PsychiatrySunnybrook Health Sciences CentreTorontoONCanada

4. Department of PsychiatryUniversity of TorontoTorontoONCanada

Funder

Alzheimer's Association

Canadian Institutes of Health Research

AbbVie

H. Lundbeck A/S

Pfizer

Sanofi

IPA

NPS

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.04.013

Reference162 articles.

1. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment

2. Behavioural changes and psychological symptoms in dementia disorders

3. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards

4. Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer’s Dementia and Death: The Cache County Dementia Progression Study

5. Neuropsychiatric Symptoms and Quality of Life in Alzheimer Disease

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review on mild behavioural impairment: an exploration into its scientific perspectives;Aging Clinical and Experimental Research;2023-07-01

2. Anesthetic‐loaded nanodroplets with focused ultrasound reduces agitation in Alzheimer's mice;Annals of Clinical and Translational Neurology;2023-01-30

3. Empirical and Authoritative Classification of Neuropsychiatric Syndromes in Neurocognitive Disorders;The Journal of Neuropsychiatry and Clinical Neurosciences;2023-01

4. Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease;Expert Opinion on Drug Safety;2022-10-03

5. Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease;Journal of Alzheimer's Disease;2022-05-03